Hunter and others like him chose Harmony™ TPV. Celebrating 1000 Harmony TPV patients treated globally — and counting! See risk info bit.ly/3TOTJJU | Learn more: bit.ly/48k5bll#HarmonyTPV1000
Hear first-hand from Hunter, born with tetralogy of Fallot, about living with Harmony™ TPV for the last 2 years — and how he lives his life to the fullest.
See risk info: bit.ly/48swJEU
Learn more: bit.ly/478MlvZ#chd#HarmonyTPV1000
Innovation with a purpose - discover what Dr. @AshishPershad says about the Evolut™ FX platform and how design enhancements have led to exceptional performance. bit.ly/3RtfaOa
People who know, think #EvolutFirst. | Risk Info: bit.ly/481BpBD
Is Evolut™ TAVR your platform of choice? Learn why Dr. @RizikMd believes in the CoreValve™/Evolut platform's performance and outcomes.
People who know, think #EvolutFirst. bit.ly/3uPGUVm | Risk Info: bit.ly/3Rjzxgz
Dr. Geoge Alravez restored Julia's health when he treated her with a supra-annular, self-expanding #TAVR for her symptomatic severe aortic stenosis. Discover why this technology is so transformative. bit.ly/47VNCI8
Risk Info: bit.ly/4aiz86B
Hear first-hand from Hunter, born with tetralogy of Fallot, about living with Harmony™ TPV for the last 2 years — and how he lives his life to the fullest.
See risk info bit.ly/3RbOXU4
Learn more: bit.ly/3RFgS0f#chd#HarmonyTPV1000
Learn why Dr. Geoge Alravez treated Julia with a supra-annular, self-expanding #TAVR for her symptomatic severe aortic stenosis. Risk Info: bit.ly/4abx6oU
Watch her full story: bit.ly/41aMcHf
Evolut™ #TAVR is the ONLY platform to show numerically lower rate of death or disabling stroke in low-risk patients at 4 years than #SAVR. Discover the outcomes: bit.ly/4ab3MPx
Risk info: bit.ly/4a8PEpN
John Rhodes M.D. reflects on recent 2-year Harmony™ TPV data and the positive outcomes seen in Hunter, one of the first to undergo the procedure. See risk info bit.ly/46Ew1Df Learn more: bit.ly/3t2BK7W#HarmonyTPV1000
Staying up to date on clinical data is critical for treating low-risk #TAVR patients. Our late-breaking clinical trial at #TCT2023 shows the safety benefits of Evolut™ TAVR in low-risk patients: bit.ly/47HkLXR
Risk info: bit.ly/47ZCb1Q
Dr. @RizikMd talks ease of use and deliverability with the EvolutTM FX system. Hear why his heart team fell in love with this #TAVR system. bit.ly/46A60VD
People who know, think #EvolutFirst. | Risk Info: bit.ly/46EHxyg
Julia was dizzy; she couldn't walk or keep up with the kids at her daycare center in Laredo, TX. But she found hope when she met Dr. George Alvarez. Watch her full story: bit.ly/3QYPrg5
Two years ago, Hunter was one of the first Harmony™ TPV recipients. But today he's one of many patients living with this valve. Hear how his TPVR, time, & hard work has added up to health and happiness.
See risk info bit.ly/3RizyTb | Learn more: bit.ly/46zSnWf
We're committed to providing the latest #TAVR data you need to make informed decisions for your patients. Download the 4-year outcomes from the Evolut Low Risk late-breaking clinical trial. bit.ly/3STgGLM
Risk info: bit.ly/3SYdeiO